Factor V Leiden thrombophilia is an inherited disorder of blood clotting . Factor V Leiden is the name of a specific gene mutation that results in thrombophilia, which is an increased tendency to form abnormal blood clots that can block blood vessels.
Hypercoagulable states are usually genetic (inherited) or acquired conditions. The genetic form of this disorder means a person is born with the tendency to form blood clots.
Hypoprothrombinemia may be inherited or acquired. Acquired hypoprothrombinemia may be an isolated factor deficiency or a condition associated with several factor deficiencies.
Preventing Blood Clots
- Wear loose-fitting clothes, socks, or stockings.
- Raise your legs 6 inches above your heart from time to time.
- Wear special stockings (called compression stockings) if your doctor prescribes them.
- Do exercises your doctor gives you.
- Change your position often, especially during a long trip.
Genetic counseling: Factor V Leiden thrombophilia (i.e., predisposition to the development of venous thrombosis) is inherited in an autosomal dominant manner. Homozygosity for the Leiden variant (and a much greater risk for venous thrombosis) are inherited in an autosomal recessive manner.
Factor V Leiden mutation and PT 20210 tests are ordered when it is suspected that a person has an inherited risk factor for blood clots, for example, when an individual: Has a first deep venous thrombosis (DVT) or venous thromboembolism (VTE) before age 50. Has recurring DVT or PE.
The prothrombin time, sometimes referred to as PT or pro time test, is a test to evaluate blood clotting. Prothrombin is a protein produced by your liver. It is one of many factors in your blood that help it to clot appropriately.
Treatment. There is no treatment for thrombophilia until you get a blood clot. What happens then depends on where the clot is, its size, and other things. If you have the antiphospholipid antibody syndrome form of thrombophilia, you may need long-term treatment with blood thinners.
People have two MTHFR genes, inheriting one from each of their parents. Mutations can affect one (heterozygous) or both (homozygous) of these genes. There are two common types, or variants, of MTHFR mutation: C677T and A1298C.
Factor II deficiency is inherited in an autosomal recessive fashion, meaning that both parents must carry the gene to pass it on to their children; it affects men and women equally.
Factor II deficiency is a very rare blood clotting disorder. It results in excessive or prolonged bleeding after an injury or surgery. Factor II, also known as prothrombin, is a protein made in your liver. It plays an essential role in blood clot formation.
It occurs when a person receives one abnormal copy of the antithrombin III gene from a parent with the disease. The abnormal gene leads to a low level of the antithrombin III protein. This low level of antithrombin III can cause abnormal blood clots (thrombi) that can block blood flow and damage organs.
Thromboplastin (TPL) or thrombokinase is a mixture of both phospholipids and tissue factor found in plasma aiding blood coagulation through catalyzing the conversion of prothrombin to thrombin. Partial thromboplastin was used to measure the intrinsic pathway.
Protein S deficiency is a rare genetic disorder of blood coagulation that is caused by a variation in the PROS1 gene. This variation is inherited in an autosomal dominant manner.
Prothrombin deficiency is a disorder caused by a lack of a protein in the blood called prothrombin. It leads to problems with blood clotting (coagulation). Prothrombin is also known as factor II (factor two).
Factor V Leiden (FAK-tur five LIDE-n) is a mutation of one of the clotting factors in the blood. This mutation can increase your chance of developing abnormal blood clots, most commonly in your legs or lungs. Most people with factor V Leiden never develop abnormal clots.
Abnormal bleeding or the development of blood clots are the most common symptoms of most coagulation system disorders.
Symptoms
- Yellowing of the skin (jaundice)
- Pain in the upper right abdomen.
- Abdominal swelling.
- Nausea.
- Vomiting.
- Feeling unwell.
- Confusion.
- Sleepiness.
Venous thrombosis (deep vein thrombosis, pulmonary embolism) is a common and serious disorder, with genetic and acquired risk factors. The genetic risk factors can be subdivided in to those that are strong, moderate and weak. Strong risk factors are deficiencies of antithrombin, protein C and protein S.
What is the MTHFR gene? The MTHFR gene provides instructions for your body to make the MTHFR protein, which helps your body process folate. Your body needs folate to make DNA and modify proteins. A gene variant is a change in a DNA sequence that is different from the expected DNA sequence.
Different conditions can be inherited in different ways; thrombophilia is considered a dominant trait. That means a person with inherited thrombophilia only has to have a mutation in one of his/her two gene copies to have the condition. This is also called dominant inheritance.
In mammals, this complex is responsible for the cleavage of prothrombin to thrombin and is composed of factor Xa in association with its cofactors calcium, phospholipids, and factor Va. The snake prothrombin activators have been classified on the basis of their requirement for cofactors for activity.
It leads to problems with blood clotting (coagulation). Prothrombin is also known as factor II (factor two).
It can be caused by:
- Lack of vitamin K (some babies are born with vitamin K deficiency)
- Severe liver disease.
- Use of medicines that prevent clotting (anticoagulants such as warfarin)
Thrombophilia is a condition that increases your risk of blood clots. It's usually treated with anticoagulant medicines.
Factor V deficiency is an inherited bleeding disorder that can cause excessive bleeding. Can Factor V Leiden skip a generation? No… genetic mutations are passed from generation to generation because we receive our DNA from our parents.
Factor V Leiden is the most common genetic predisposition to blood clots. Individuals born with FVL are more likely to develop vein clots (deep vein thrombosis or DVT) and pulmonary embolism (PE), but not heart attacks, strokes or blood clots in the arteries of the legs.
It's difficult to qualify for disability due to thrombosis, unless it has led to chronic venous insufficiency (CVI). People who have deep vein thrombosis are at risk for pulmonary embolism or stroke, both life-threatening conditions, and are sometimes advised not to work.
Heterozygous means that the 2 copies of a gene are different. In your case, one of your Factor V gene codes is for normal clotting Factor V and the other Factor V gene code is for Factor V Leiden. There is more risk of a blood clot if both gene codes are for Factor V Leiden (ie in the homozygous state).
A blood test (called a screening test) can show if you have Activated Protein C resistance. If you do, another blood test that examines your genes (called DNA) will be done to find out if Factor V Leiden is the cause of the resistance and what type of Factor V Leiden you have.
Though factor V Leiden alone does not seem to raise the risk of arterial clots, something as simple as daily therapy with low-dose aspirin may help prevent a heart attack or stroke in people with factor V Leiden if they have additional risk factors.
Many people with prothrombin-related thrombophilia never develop abnormal blood clots. This condition is caused by a particular genetic variant (written G20210A or 20210G>A) in the F2 gene and is inherited in an autosomal dominant pattern.
